Recent advances in the treatment of opiate addiction

Current Psychiatry Reports
Paul Fudala, George E Woody

Abstract

Although addiction to heroin and other opiates is a major public health issue in the United States and many other countries, advances in pharmacologic and nonpharmacologic treatment have been made. Some of these advances represent a major shift from traditional treatment philosophies, whereas others are characterized by more subtle, though important, improvements. This review discusses recent advances in opiate-addiction treatment in the context of three main domains: the use of buprenorphine and buprenorphine/naloxone in an office-based paradigm, psychosocial treatment and the addressing of medical and psychiatric comorbidity, and harm reduction strategies.

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Nov 1, 1985·Archives of General Psychiatry·G E WoodyC P O'Brien
Aug 1, 1995·American Journal of Public Health·P Reuter, J P Caulkins
Feb 1, 1994·American Journal of Public Health·A Umbricht-SchneiterG E Bigelow
Apr 21, 1993·JAMA : the Journal of the American Medical Association·A T McLellanC P O'Brien
Nov 1, 1996·Addictive Behaviors·G A Marlatt
Mar 26, 1998·The American Journal of Drug and Alcohol Abuse·M A ChutuapeM L Stitzer
Oct 28, 1998·Journal of Addictive Diseases·B J MasonM J Kreek
Sep 24, 1999·European Journal of Pharmacology·K O LeeJ R Traynor
Dec 28, 1999·Journal of Urban Health : Bulletin of the New York Academy of Medicine·S A StrathdeeD Vlahov
Mar 31, 2000·Journal of Urban Health : Bulletin of the New York Academy of Medicine·H HaganE R Alexander
Mar 21, 2001·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·S F ButlerJ S Cacciola
Oct 12, 2001·JAMA : the Journal of the American Medical Association·C WeisnerY Lu
Apr 16, 2002·Journal of Consulting and Clinical Psychology·Nancy M Petry, Bonnie Martin
Oct 9, 2002·Addictive Behaviors·Stephen T HigginsRobert L Dantona
May 10, 2003·Drug and Alcohol Dependence·Jerome H Jaffe, Charles O'Keeffe
Aug 9, 2003·BMJ : British Medical Journal·Wim van den BrinkJan M van Ree
Aug 14, 2003·JAMA : the Journal of the American Medical Association·Brian Vastag
Apr 22, 2004·JAMA : the Journal of the American Medical Association·Edward V Nunes, Frances R Levin
May 18, 2005·Acta Paediatrica. Supplement·V Gieselmann

❮ Previous
Next ❯

Citations

Aug 6, 2013·Paediatric Drugs·Anna PecoraroGeorge E Woody
May 14, 2008·Expert Opinion on Pharmacotherapy·Francesco Leri
Mar 29, 2011·The American Journal of Drug and Alcohol Abuse·Zhao MinZhang Mingyuang
Sep 24, 2011·Journal of Substance Abuse Treatment·Bobby P SmythKathy Kernan
Oct 31, 2006·Trends in Molecular Medicine·Ruben D Baler, Nora D Volkow
Mar 28, 2006·Drug and Alcohol Dependence·Paul J Fudala, Rolley E Johnson
Jan 8, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David S MetzgerUNKNOWN HPTN 058 Protocol Team
May 12, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Marco CespiGiovanni F Palmieri
Apr 11, 2015·International Journal of Cancer. Journal International Du Cancer·Yuk-Kit ChanPatrick Ying-Kit Yue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.